Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Trans fatty acids

This article was originally published in The Tan Sheet

Executive Summary

FDA reopens until Jan. 19 comment period on prudence of listing trans fatty acids in "Nutrition Facts" labeling and whether terms "reduced trans fat" and "reduced saturated and trans fat" should be better defined in nutrient content claims for foods, including dietary supplements, according to recent Federal Register notice. Proposed rule was published by agency Nov. 17, 1999 (1"The Tan Sheet" Nov. 15, 1999, In Brief)

You may also be interested in...



Trans Fat Footnote Statement On Food, Supplement Labeling Proposed By FDA

FDA is seeking comments on the proposed use of a footnote statement on food and dietary supplement products containing trans fat that would advise consumers against excessive intake of the ingredient

Trans Fat Footnote Statement On Food, Supplement Labeling Proposed By FDA

FDA is seeking comments on the proposed use of a footnote statement on food and dietary supplement products containing trans fat that would advise consumers against excessive intake of the ingredient

Trans Fat Footnote Statement On Food, Supplement Labeling Proposed By FDA

FDA is seeking comments on the proposed use of a footnote statement on food and dietary supplement products containing trans fat that would advise consumers against excessive intake of the ingredient

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092021

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel